Have you been diagnosed with Type 2 Diabetes and are interested in participating in a research study?
ECU Diabetes Research Center is participating in a trial comparing the efficacy and safety of insulin degludec and insulin glargine 300 units/mL in subjects with type 2 diabetes mellitus inadequately treated with basal insulin with or without oral anti-diabetic drugs.
To compare the effects of Troujeo and Tresiba on hypoglycemic events
The research study will take 1 year
Participants will need to be over 18 years old, not using bolus insulin, check their blood sugars, follow the protocol and timeline provided for medication adjustments, phone calls, and clinic visits.
Decreased Hypoglycemic events
Improved Glycemic Control (Blood Glucose Control)
Free Medicines and testing supplies
The research study is being run by the ECU Diabetes Research Center.
The Primary Investigator is Dr. Robert Tanenberg